The impact of health care settings on survival time of patients with chronic myeloid leukemia

Blood

Volumn 123, Issue 16, 2014, Pages 2494-2496

  Lauseker, Michael ^a   Hasford, Joerg ^a   Pfirrmann, Markus ^a   Hehlmann, Rüdiger ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; HAZARD RATIO; HEALTH CARE; HEALTH SERVICE; HOSPITAL; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MUNICIPAL HOSPITAL; OFFICE BASED PHYSICIAN; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL COMPETENCE; GERMANY; HEALTH FACILITIES; HOSPITALS, MUNICIPAL; HOSPITALS, TEACHING; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MIDDLE AGED; PHYSICIANS' OFFICES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84899063141     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-11-539742     Document Type: Article

References (6)

1. Clark J, Tugwell P. Does academic medicine matter? PLoS Med. 2006;3(9):e340.
2. Hehlmann R, Lauseker M, Jung-Munkwitz S, et al. Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-a in newly diagnosed chronic myeloid leukemia. J Clin Oncol. 2011;29(12):1634-1642.
3. Hehlmann R, Müller MC, Lauseker M, et al. Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-Study IV. J Clin Oncol. 2014;32(5):415-423.
4. Hasford J, Baccarani M, Hoffmann V, et al. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score. Blood. 2011;118(3):686-692.
5. Papanikolaou PN, Christidi GD, Ioannidis JPA. Patient outcomes with teaching versus nonteaching healthcare: a systematic review. PLoS Med. 2006;3(9):e341.
6. Klimm B, Brillant C, Skoetz N, Müller H, Engert A, Borchmann P. The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphoma. Dtsch Arztebl Int. 2012; 109(51-52):893-899.